Skip to main content

Table 1 Demographics, clinical and surgical data, oncological treatment, and outcomes for women 18–40 years old diagnosed with epithelial ovarian cancer in Sweden 2008–2015

From: A Swedish Nationwide prospective study of oncological and reproductive outcome following fertility-sparing surgery for treatment of early stage epithelial ovarian cancer in young women

  Treated with FSS Treated with RS P-value
N (%) 36 (43) 47 (57)  
Mean age, years (range) 29 (19–39) 37 (26–40) < 0.001
Previous parity, n (%)    < 0.001
 0 27 (75) 16 (34)  
 1 6 (17) 7 (15)  
 2 2 (6) 17 (36)  
 ≥3 0 4 (9)  
FIGO stage, n (%)    0.002
 IA 27 (75) 18 (38)  
 IB  
 IC 9 (25) 29 (62)  
IC1 6 19  
IC2 3 6  
IC3 0 2  
IC unspecified 0 2  
Histologic type, n (%)
 Serous, high-grade 2 (6) 6 (13)  
 Serous, low-grade 1 (3) 2 (4)  
 Mucinous 18 (50) 12 (26)  
 Endometrioid 10 (28) 12 (26)  
Grade 1 6 4  
Grade 2 2 3  
Grade 3 1 3  
 Clear cell 3 (8) 13 (28)  
Other a 2 (6) 2 (4)  
Surgical mode,b n (%) 27 (75) 41 (87) 0.241
Open 6 (17) 3 (6)  
Laparoscopy
Robot
3 (8) 3 (6)  
Type of surgery, n (%)
 Primary 17 (47) 20 (43) 0.824
 Re-staging 19 (53) 27 (57)  
Type of staging procedure, n (%)
 Cytology 33 (92) 39 (83)  
 Peritoneal biopsies 30 (83) 39 (83)  
 Oment biopsy 31 (86) 45 (96)  
 LN pelvic 8 (22) 24 (51)  
 LN paraaortic 8 (22) 22 (47)  
Adjuvant chemotherapy, n (%) 14 (39) 34 (72) 0.003
Histologic review,c
n (%)
33 (92) 42 (89) 1.0
Recurrence, n (%) 2 (6) 6 (13)  
Died of disease, n (%) 1 (3) 2 (4)  
Follow-up, months,
mean (range)
63 (16–111) 64 (21–112) 0.708
  1. a Mixed type, adenocarcinoma unspecified; b If primary surgery is laparoscopic and re-staging laparotomy, patient is classified as laparotomy; c Histologic review by a pathologist with expertise in gynecologic oncology; FSS Fertility-sparing surgery, RS Radical surgery, LN Lymph node